GlassScriptPhysician profile
Brent D Speak
NPI 1063681419
$579.27
in general payments reported to CMS, 2019-2025
11 companies · $37.31 in 2025
The $37.31 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $93.55 · 2021: $119 · 2022: $39.28 · 2023: $116 · 2024: $33.01 · 2025: $37.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.94 | 2019-2022 | |
| Pfizer INC. | $96.66 | 2021 | |
| Organon LLC | $54.31 | 2023-2025 | Nexplanon |
| Mycovia Pharmaceuticals, INC. | $23.29 | 2023 | Vivjoa |
| Sumitomo Pharma America, INC. | $21.71 | 2023 | Myfembree |
| Astellas Pharma US INC | $20.75 | 2023 | Veozah |
| Resmed Corp | $19.73 | 2025 | |
| Merck Sharp & Dohme LLC | $19.26 | 2019 | |
| Agile Therapeutics, INC. | $15.85 | 2023 | Twirla |
| Medtronic, INC. | $15.55 | 2023 | Interstim |
| Coopersurgical, INC. | $15.22 | 2024 | Fisherbrand Disposable Liquid Infant Heel Warmer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Speak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.